Skip to main content

APO NV400 (Nevirapine Extended-Release 400 mg)

Pill with imprint APO NV400 is Yellow, Elliptical/Oval and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Apotex Corp.

Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO NV400

Nevirapine extended-release 400 mg APO NV400

Nevirapine Extended-Release

Imprint
APO NV400
Strength
400 mg
Color
Yellow
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
NNRTIs
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-4058 (Discontinued)
Inactive Ingredients
ferric oxide yellow, magnesium stearate, hypromelloses, methylcellulose (15 mPa.s)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.